Clean · Consistent · Scalable

Pure plants, grown at scale.

We mass-produce genetically identical, pathogen-free plants across a wide range of species, alongside natural biostimulant inputs. Together, these let us manufacture the plant and supply the input that helps it thrive, sustainably and without chemical dependency. It’s all driven by our research lab, which advances new species, verticals, and formulations.

Two
core focuses, one research lab
Identical
pathogen-free plant clones
Natural
biostimulant inputs, no harsh chemicals
Scalable
from one plant to millions

One platform

Two core focuses, driven by our research division.

Everything we do grows from one core competency in the lab. Our research feeds both production engines: tissue culture for pure plants at scale, and natural biostimulants that replace chemical fertilizers. Those biostimulants, in turn, power the very plants we grow in tissue culture.

Production

Identical, pure plants at scale.

Our core capability is plant tissue culture: mass-producing genetically identical, pathogen-free plants across many species in the lab. We take one superior plant and multiply it into thousands, even millions, of identical, disease-free, ready-to-plant clones.

It is the engine behind everything Endless Biotech does, and a durable market in its own right, spanning reforestation to the future of food.

Trees

Reforestation-grade, disease-free planting stock to fulfill multi-billion-tree pledges and sustainable replant obligations.

Controlled crops

Uniform, high-performance starts for controlled-environment and specialty agriculture, consistent from the very first plantlet.

Food sustainability

Clean, resilient, high-yield plants that help secure the food supply against disease, climate stress, and fragile seed pipelines.

From one plant to millions, in the lab
01

Select an elite parent

We start from one superior, proven plant, the genetics we want to replicate.

02

Multiply in sterile culture

That tissue is multiplied into thousands of plantlets under fully sterile lab conditions.

03

Verify pathogen-free

Every batch is cultured and screened to be free of viruses, fungi, and pests.

04

Deliver at scale

Identical, ready-to-plant stock ships in the volumes real production requires.

Why lab-grown plants win

Genetically identical

Every plant is a clone of one proven, elite parent, the exact same genetics in every plant, for uniform growth, form, and resilience across an entire field or forest.

Pathogen-free

Grown from clean tissue in a sterile lab, our plants are certified free of the viruses, fungi, and pests that spread through seed- and cutting-grown nurseries.

Many species, year-round

Lab micropropagation is decoupled from seed supply and season, so we scale from a single plant to millions, on a schedule, not a harvest.

Agriculture

A natural alternative to chemical fertilizers.

Developed in our research lab, our proprietary biostimulant is fully natural, and our internal data shows significant results. It is a direct replacement for the synthetic, chemical-based inputs increasingly tied to cancer and environmental damage.

A clean alternative to chemical fertilizers

Conventional fertilizers are synthetic, chemical-based, and increasingly linked to cancer and environmental harm. Ours is fully natural: no synthetic nitrogen, no phosphate runoff, no residues of concern.

It's a biostimulant, not a fertilizer

Rather than force-feeding chemicals, it primes the plant's own biology, boosting nutrient uptake, growth, stress tolerance, and self-repair.

Backed by our internal data

In our controlled internal studies, treated plants germinated strongly, grew markedly larger, and recovered from pest damage.

Where it works

TreesControlled cropsFood sustainabilityOrchids

The commercial play: the global biostimulant market is a multi-billion-dollar category compounding at double digits. Our path is to produce in bulk and license the IP to established manufacturers, turning a breakthrough formulation into recurring, high-margin revenue.

Trial results

Melissa officinalis (lemon balm) · hydroponic study

Higher
seed germination
Greater
total plant mass
Reduced
leaf loss after pest damage
Active
leaf healing observed

Representative results from a controlled hydroponic study of a natural extract biostimulant. Full methodology available to partners under NDA.

The engine

Research that powers the platform.

Our lab is where new capability is born: the science that feeds both our tissue culture and biostimulant programs, and pushes toward what's next.

Enhancements, non-GMO

Improving vigor, yield, and resilience through natural means. We enhance what the plant already is, without genetic modification.

Proprietary agar

Our own growth-media chemistry, the foundation that makes reliable, high-throughput tissue culture possible across species.

Species-specific formulas

Tailored culture protocols tuned to each species, so plants that resist standard methods can finally be cloned cleanly and at scale.

Toward natural cures

Helping cure through natural, sustainable methods.

Some of medicine's most important molecules are still tied to slow-growing, threatened plants. We're researching sustainable, scalable ways to produce them, entirely naturally, targeting some of the hardest conditions in modern health.

Cancer

Advancing natural, scalable routes to compounds behind frontline cancer therapies, grown sustainably instead of stripped from slow-growing, threatened plants.

Opioid addiction

Researching naturally occurring compounds with striking promise for interrupting opioid dependence, produced ethically and at scale, without harvesting the wild.

PTSD

Exploring plant-derived therapies that show potential to help the millions living with trauma, sourced through sustainable biology rather than fragile supply chains.

These are active research initiatives conducted within all applicable legal and regulatory frameworks. Nothing here is a medical claim or an offer of treatment.

Who we are

The team growing the future of plant biotechnology.

Travis Dahm

Travis Dahm

Founder & Chief Executive Officer

Travis founded Endless Biotech and sets the company's vision and strategy, building the partnerships and commercial pathways that turn breakthrough science into real-world impact, from forestry pilots to licensing agreements with global manufacturers.

Dr. William Ranahan

Dr. William Ranahan

Chief Scientific Officer

The scientific engine of Endless Biotech. Dr. Ranahan leads our tissue culture, biostimulant, and natural-compound research programs, the inventor behind our breakthrough biostimulant and the driving force taking our forestry and compound initiatives from the lab toward scale.

Teddy Pillay

Teddy Pillay

Chief Operating Officer

Teddy runs day-to-day operations and growth, connecting the company's research with the partners and execution needed to bring sustainable biotechnology to a global market.

Ben Kimbro

Ben Kimbro

Chief of Staff

Ben keeps the company aligned and moving, coordinating strategy, operations, and communication across the team so that research, production, and partnerships advance in step.

Valin Bodie

Valin Bodie

Lab Director

Valin runs the lab day to day, overseeing tissue culture and biostimulant work at the bench and turning research protocols into reliable, repeatable production.

Team bios are a first draft, easily updated with each person’s preferred title and background.

Let’s grow what the world needs.

We work with forestry and agricultural leaders, manufacturers, and research institutions to bring sustainable biotechnology to global scale. If tissue culture, biostimulants, or our research resonate, we’d love to talk.

Tissue Culture
supply & production partnerships
Biostimulants
bulk supply & IP licensing
Research
scientific collaboration